Rebound Intracranial Hypertension

1

Review clinical trials related to Rebound Intracranial Hypertension. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

ONSD Trajectory in Rebound ICH

The goal of this prospective observational study is to determine whether the trajectory of optic nerve sheath diameter (ONSD) after osmotherapy weaning can predict rebound intracranial hypertension in adult patients with traumatic brain injury requiring osmotherapy for elevated intracranial pressure. The main questions it aims to answer are: Does the trajectory of ONSD during osmotherapy weaning predict the development of rebound intracranial hypertension? What is the diagnostic accuracy of serial ONSD measurements for the early detection of rebound intracranial hypertension? Researchers will compare patients who develop rebound intracranial hypertension with those who do not to determine whether changes in ONSD trajectory differ significantly between the two groups. Participants will: Undergo serial bedside ocular ultrasound examinations for ONSD measurement at predefined time points after osmotherapy weaning. Receive standard clinical management for traumatic brain injury according to institutional protocols; no additional therapeutic intervention will be administered. Undergo routine neurological assessments, laboratory investigations, and neuroimaging as clinically indicated. Be followed for the occurrence of rebound intracranial hypertension and relevant clinical outcomes during their ICU stay

Participants needed: 100
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Benha UniversityUpdated: Jul 23, 2026Locations: 1Duration: 6 Weeks
Eligibility criteria

Adults (≥18 years) with blunt traumatic brain injury admission GCS ≤12 [+2]

Ocular conditions precluding ONSD measurement (glaucoma, prior ocular surgery, [+3]